Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 55, Issue 1, Pages 115-125Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm2010767
Keywords
-
Categories
Ask authors/readers for more resources
Chemical strategies to mitigate cytochrome P450-mediated bioactivation of novel 2,7-disubstituted pyrrolo[2,1-f][1,2,4]triazine ALK inhibitors are described along with synthesis and biological activity. Piperidine-derived analogues showing minimal microsomal reactive metabolite formation were discovered. Potent, selective, and metabolically stable ALK inhibitors from this class were identified, and an orally bioavailable compound (32) with antitumor efficacy in ALK-driven xenografts in mouse models was extensively characterized.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available